Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-079312·IGM Biosciences, Inc.
Schedule 13D ownership disclosure
N/A
Common Stock, par value $0.01 per share · CUSIP: 449585108
Event date: 2025-08-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Redmile Group, LLCReported CIK 0001425738
Shares: 0.00 · Class: 0.0%
- Jeremy C. GreenReported CIK 0001650527
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-079312
- Form type
- SCHEDULE 13D/A
- Filer
- IGM Biosciences, Inc.
- CIK
- CIK 1496323
- Filed
- Aug 15, 2025
- Reporting period
- Aug 14, 2025
- Description
- Schedule 13D beneficial ownership